538965 Stock Overview
Engages in the manufacture and sale of pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Concord Drugs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹35.97 |
| 52 Week High | ₹61.50 |
| 52 Week Low | ₹30.59 |
| Beta | 0.37 |
| 11 Month Change | 6.61% |
| 3 Month Change | -2.68% |
| 1 Year Change | 3.69% |
| 33 Year Change | 21.52% |
| 5 Year Change | 112.21% |
| Change since IPO | 79.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 538965 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.2% | 0.5% | 0.5% |
| 1Y | 3.7% | 42.5% | 27.5% |
Return vs Industry: 538965 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 538965 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 538965 volatility | |
|---|---|
| 538965 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 538965 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 538965's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 185 | Seelam Reddy | concorddrugs.in |
Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products. The company also provides ready-to-fill pellets and multiple unit pellets system; drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers.
Concord Drugs Limited Fundamentals Summary
| 538965 fundamental statistics | |
|---|---|
| Market cap | ₹359.70m |
| Earnings (TTM) | -₹5.09m |
| Revenue (TTM) | ₹524.80m |
0.7x
P/S Ratio-70.6x
P/E RatioIs 538965 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 538965 income statement (TTM) | |
|---|---|
| Revenue | ₹524.80m |
| Cost of Revenue | ₹430.28m |
| Gross Profit | ₹94.51m |
| Other Expenses | ₹99.61m |
| Earnings | -₹5.09m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.51 |
| Gross Margin | 18.01% |
| Net Profit Margin | -0.97% |
| Debt/Equity Ratio | 56.3% |
How did 538965 perform over the long term?
See historical performance and comparison